Combination of sodium stibogluconate and rifampicin in post kala-azar dermal leishmaniasis.
Sharma
V K
VK
Prasad
H R Y
HR
Sethuraman
G
G
Khaitan
B K
BK
D000328:Adult; D000967:Antimony Sodium Gluconate / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy* / Q000209:etiology*; D007898:Leishmaniasis, Visceral / Q000150:complications*; D008297:Male; D012293:Rifampin / Q000627:therapeutic use*
D000981:Antiprotozoal Agents; D000967:Antimony Sodium Gluconate; D012293:Rifampin